Viking selected VK2735 from a series of internally developed dual GLP-1/GIP receptor agonists evaluated as part of a program focused on the development of best-in-class therapies for metabolic diseases
Lifestyle Habits Medication works best when paired with realistic, sustainable habits, not extreme restriction
Research has shown that GLP-1 receptor agonists can promote the formation of cyclic adenosine monophosphate in thyroid C cells, increasing serum calcitonin synthesis and release, which may lead to the occurrence of thyroid C cell carcinoma
6 Patient Preferred Daytime Phone Number Format Validation Validates that the preferred daytime phone number is present and matches an acceptable phone format (e.g., 10-digit NANP with optional country code, parentheses, spaces, or hyphens)
Oh, S., Kim, E
It is not a GLP-1 agonist drug, nor is it intended to replace GLP-1 agonist drugs